| Status | Topic selection |
| Technology type | Medicine |
| Decision | Selected |
| Reason for decision | Not eligible for Health Technology Evaluation guidance |
| Further information | The NICE-Wide Prioritisation Board and NHS England have agreed that a Technology Appraisal (TA) would not be appropriate for this product and recommended that it is not selected for evaluation. Decision makers concluded that the clear rationale to not select is due to being a paediatric licence extension of the published adult TA456. NHS England will commission treatments for patients aged less than 18 years where specific commissioning conditions are met as per the Commissioning medicines for children in specialised services policy. |
| ID number | 11955 |
Project Team
| Project lead | Danielle Lees |
Email enquiries
- If you have any queries please email topic.selection@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 10 September 2024 | Topic selection |
| 10 September 2024 | Topic selection |
For further information on how we select topics for development, please see our page about topic selection